8 Patient Recruitment Companies Operating in Europe in 2026

Every clinical trial depends on finding enough of the right patients quickly enough, and a patient recruitment provider exists to close that gap through advertising, referral networks, patient communities, or direct-to-GP outreach. Across continental Europe, that work has to account for fragmented national regulatory frameworks and language, since a recruitment approach that works in one country's health system often needs rebuilding for the next. This kind of clinical trial recruitment service ranges from software platforms that centralize and track every recruitment channel to on-the-ground teams working through general practitioners and patient advocacy groups.

The patient recruitment companies below, headquartered in Sweden, Austria, Denmark, Bulgaria, Poland, Spain, and the Netherlands, are listed in no particular order. Between them, these companies and providers cover SaaS recruitment platforms, GP referral networks, patient-facing trial-matching search engines, and community-based outreach to underrepresented populations.

Trialbee

Trialbee built its business around the Honey Platform, a SaaS product that centralizes and standardizes patient recruitment activity from every channel and referral source into one system for sites, sponsors, and CROs. Founded in 2010 and based in Malmö, Sweden, the company screened its one-millionth patient on the platform in 2025 and has since added AI-powered features aimed at flagging enrollment risks earlier. Honey's two-step pre-qualification process, which includes medical secondary screening, disqualifies roughly 75 percent of web-based submissions before they reach a site. Trialbee has co-presented with sponsors including Bristol Myers Squibb on using the platform for trial-finder websites.

Probando

Probando runs a recruitment platform intended to bridge the gap between patients and clinical trials using targeted digital strategies, paired with Probando Pay, its own digital reimbursement tool for participant compensation. Based in Graz, Austria, the company positions its recruitment process around keeping patients informed and engaged throughout the trial journey rather than treating enrollment as a single transaction. Probando's technology-driven matching approach is aimed at making participation in medical research more accessible to a broader patient population. The company frames participant compensation as a core part of the recruitment experience, not an administrative afterthought.

James Lind Care

James Lind Care operates its own digital patient communities, with more than 250,000 members across Europe, that it uses to identify and guide participants toward clinical trials matching their condition. Founded in 2011 and based in Copenhagen, the company staffs a team of research nurses in each European country where it operates, who train on a trial's protocol before referring qualified patients to sites. In one published case, the company supported a cardiovascular HFpEF trial across two countries and 12 sites, successfully randomizing 24 patients through its recruitment process. Membership in James Lind Care's patient communities is free, and the company reports the approach helps keep screen-failure rates low and randomization rates high.

FindMeCure

FindMeCure operates two linked platforms: a patient-facing search engine that helps people locate relevant clinical trials, and TrialHub, a separate data-intelligence product it built for sponsors and CROs to plan recruitment and assess trial feasibility. Founded in 2015 and based in Sofia, Bulgaria, the company also runs the nonprofit FindMeCure Foundation, which estimates that only 15 percent of patients know clinical trials are a treatment option at the time of diagnosis. FindMeCure's search platform has served close to a million people worldwide looking for trial information. The company has partnered with Indegene to expand patient inclusion efforts through the TrialHub platform.

gp4research

gp4research operates as an investigative site network built around general practitioners and community nurses, using the trust GPs have built with their patients over years to identify and recruit trial candidates. A spin-off of the Medical University of Gdańsk that won the 2019 EIT Health Start-ups Meet Pharma competition, the Poland-based company trains its GP network to ICH-GCP standards across the European countries where it operates. Each GP in the network maintains a dedicated pool of roughly 2,000 patients, cared for from childhood through adulthood, which the company draws on for late-phase and observational studies in primary-care-relevant therapeutic areas. gp4research also coordinates home health services for decentralized trials through a partnership with Medsource.

Patiro

Patiro offers a pay-only-per-enrolled-patient recruitment model, meaning sponsors pay for participants who actually enroll rather than for advertising activity that doesn't convert. Founded in Denmark in 2014 to address trial delays caused by recruitment challenges, the company has since built a network spanning more than 2,000 clinical sites across 44 countries, with a focus on rare disease and oncology recruitment. Case studies the company has published report a 65 percent reduction in participant dropout rates and 40 percent faster recruitment timelines. Patiro pairs direct-to-patient digital outreach with referral and community channels to reach candidates outside a study's usual specialist pipeline.

Un Ensayo para Mí

Un Ensayo para Mí, formerly known as Trialtech, recruits clinical trial volunteers specifically from Latin America and the Latino community in the United States, running Spanish-language outreach and referral technology built for that population. Based in Madrid, the company develops targeted communication strategies by population segment and trains its patient-management team on each study's protocol before referring qualified candidates to investigators. It also operates a referrals app that lets partner physicians search trials, check inclusion and exclusion criteria, and refer patients to their preferred sites directly. The company works with patient associations across Latin America on informational and educational activities intended to raise awareness of clinical trial participation.

Mytomorrows

Mytomorrows began in 2012 as an expanded-access platform, founded by Ronald Brus after his father was unable to access a potentially life-saving drug still in development, and added clinical trial recruitment as a service line in 2020. Headquartered in Amsterdam with an office in New York, the company has enrolled more than 16,900 patients and connected with over 340 trial sites to date, according to its own figures. In 2025 the company added an AI-powered referral management tool that lets trial sites share real-time trial information and unify pre-screening across previously fragmented referral processes. Mytomorrows charges biopharma clients for its recruitment, expanded-access management, and real-world data collection services.

Explore the full Patient Recruitment landscape

The companies above represent a portion of a much larger field.

Diligent's platform includes over 730 Patient Recruitment Vendors, with Vendor qualification data available on demand. Talk to our team about accessing qualification data for this category.

This article is intended as an informational overview of vendors operating in this space. Inclusion on this list does not constitute an endorsement, recommendation, or qualification by Diligent.